John Canan - Net Worth and Insider Trading
John Canan Net Worth
The estimated net worth of John Canan is at least $2 Million dollars as of 2024-12-16. John Canan is the Sr.V-P Finc-Global Controller of Merck & Co Inc and owns about 14,043 shares of Merck & Co Inc (MRK) stock worth over $1 Million. John Canan is also the Director of REV Group Inc and owns about 6,363 shares of REV Group Inc (REVG) stock worth over $224,168. Details can be seen in John Canan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Canan has not made any transactions after 2018-06-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Canan
John Canan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Canan owns 4 companies in total, including Grace Therapeutics Inc (GRCE) , REV Group Inc (REVG) , and Merck & Co Inc (MRK) among others .
Click here to see the complete history of John Canan’s form 4 insider trades.
Insider Ownership Summary of John Canan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GRCE | Grace Therapeutics Inc | 2020-04-01 | director |
| REVG | REV Group Inc | 2018-06-25 | director |
| MRK | Merck & Co Inc | 2014-02-11 | Senior V-P & Controller |
 | | 2009-11-03 | Senior V-P & Controller |
John Canan Latest Holdings Summary
John Canan currently owns a total of 2 stocks. Among these stocks, John Canan owns 14,043 shares of Merck & Co Inc (MRK) as of February 11, 2014, with a value of $1 Million and a weighting of 86.47%. John Canan also owns 6,363 shares of REV Group Inc (REVG) as of June 25, 2018, with a value of $224,168 and a weighting of 13.53%.
Latest Holdings of John Canan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRK | Merck & Co Inc | 2014-02-11 | 14,043 | 102.00 | 1,432,386 |
| REVG | REV Group Inc | 2018-06-25 | 6,363 | 35.23 | 224,168 |
Holding Weightings of John Canan
John Canan Form 4 Trading Tracker
According to the SEC Form 4 filings, John Canan has made a total of 0 transactions in Merck & Co Inc (MRK) over the past 5 years. The most-recent trade in Merck & Co Inc is the sale of 10,000 shares on February 11, 2014, which brought John Canan around $557,000.
According to the SEC Form 4 filings, John Canan has made a total of 0 transactions in REV Group Inc (REVG) over the past 5 years. The most-recent trade in REV Group Inc is the acquisition of 5,040 shares on June 25, 2018, which cost John Canan around $80,842.
Insider Trading History of John Canan
- 1
John Canan Trading Performance
GuruFocus tracks the stock performance after each of John Canan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Canan is -6.43%. GuruFocus also compares John Canan's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Canan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Canan's insider trading performs compared to the benchmark.
Performance of John Canan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.94 | | | | | |
| Relative Return to S&P 500(%) | -7.69 | | | | | |
John Canan Ownership Network
Ownership Network List of John Canan
Ownership Network Relation of John Canan
John Canan Owned Company Details
What does Grace Therapeutics Inc do?
Who are the key executives at Grace Therapeutics Inc?
John Canan is the director of Grace Therapeutics Inc. Other key executives at Grace Therapeutics Inc include Chief Medical Officer R. Loch Macdonald , Chief Executive Officer Prashant Kohli , and VP Clinical Operations Carrie D'andrea .
Grace Therapeutics Inc (GRCE) Insider Trades Summary
Over the past 18 months, John Canan made no insider transaction in Grace Therapeutics Inc (GRCE). Other recent insider transactions involving Grace Therapeutics Inc (GRCE) include a net purchase of 676,371 shares made by Vimal Kavuru , and a net purchase of 381 shares made by Donald Olds .
In summary, during the past 3 months, insiders sold 0 shares of Grace Therapeutics Inc (GRCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Grace Therapeutics Inc (GRCE) were sold and 676,752 shares were bought by its insiders, resulting in a net purchase of 676,752 shares.
Grace Therapeutics Inc (GRCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Grace Therapeutics Inc Insider Transactions
John Canan Mailing Address
Above is the net worth, insider trading, and ownership report for John Canan. You might contact John Canan via mailing address: C/o Rev Group, Inc., 111 East Kilbourn Avenue, Suite 2600, Milwaukee Wi 53202.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
